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Purpose: To describe clinical presentation, management, and outcomes 
of central toxic keratopathy developing after surface laser refractive 
surgeries. 
Patients and Methods: In this retrospective case series, the records 
of 10 eyes of 5 patients (1 male, 4 female) were reviewed. The laser 
refractive surgery consisted of photorefractive surgery (PRK; 2eyes) and 
laser-assisted subepithelial keratectomy (LASEK; 8 eyes). Mitomycin C, 
0.02  % was applied intraoperatively in all eyes. 
Results: The mean patient age was 30 ± 14.5 years, (22 to 56 years). 
Presenting symptom was decreased vision without pain or photophobia in 
all cases that began 3 to 9 days postoperatively. The slit-lamp examination 
revealed corneal opacities and corneal thinning in the central area of the 
cornea corresponding to the ablated zone. There were no corneal epithelial 
defects or corneal stromal infiltration. Upon presentation, the mean best-
corrected distance visual acuity was 20/25 (LogMAR 0.83 ± 0.34). The 
opacification persisted for a minimum of two months to a maximum of 
6 months before clearing. The patients were followed up for 12 months. 
Five eyes had a decrease of 1 to 2 lines in preoperative best-corrected 
distance visual acuity 6 months postoperatively. All eyes had hyperopic 
shift and astigmatism during the follow-up period. The mean spherical 
equivalent at final follow up was + 0.75 ± 1.15 diopter.
Conclusion:  Central toxic keratopathy is a non-inflammatory central 
corneal opacification which is associated with significant hyperopic shift 
and stromal tissue loss. Visual prognosis is usually good but a decrease in 
best-corrected distance visual acuity may persist in some cases. 
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Introduction
Central toxic keratopathy (CTK) is described 
as a rare, self-limited, non-inflammatory 
postsurgical condition that manifests with 
central corneal opacity and a significant 
hyperopic shift 1. It resembles a number of 
other eye diseases like post-photorefractive 
keratectomy (PRK) haze, infectious keratitis, 
contact lens-induced keratitis, diffuse lamellar 
keratitis (DLK), and epithelial ingrowth 1. 
CTK is very uncommon after surface 
laser refractive surgery. Central corneal 
opacification typically develops 3-9 days 
after refractive surgery, and stromal shrinkage 
results in significant hyperopic shift. Although 
striae are a characteristic feature of CTK, the 
condition can exist in the absence of striae. 
The findings in CTK typically resolve in 2 to 
18 months. 
Fraenkel et al., 2 reported the first case series of 
diffuse lamellar keratitis (DLK) consisting of 
four eyes with central focal interface opacities 
that developed within one week after laser in 
situ keratomileusis (LASIK). They observed 
a circular opacity located centrally within 
the LASIK interface, which was associated 
with stromal folds, variable thinning, and 
hyperopic shift 2. Based on clinical response 
to topical steroids, they suggested that this 
complication is caused by an inflammatory 
response and concluded that treatment with 
steroids allowed stromal regeneration and 
resolution of the opacification 2. This theory is 
not supported by other investigators. Sonmez 
et al., 3 who described CTK after surface laser 
ablation argued that this condition is a non-
inflammatory opacification that is clinically 
distinct from DLK. 
Here we describe clinical presentation, 
management, and outcomes of CTK developing 
after surface laser refractive surgeries. 
Patients and Methods 
This retrospective case series included 10 
eyes from 5 patients (1 male, 4 female), 
aged between 22 and 56 years old. Ethics 
committee approval was obtained from the 
Ophthalmic Research Center, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran. 
The patients underwent PRK (2 eyes) or laser-
assisted subepithelial keratectomy (LASEK) 
(8 eyes), performed by the same surgeon 
in three private eye clinics. Mitomycin C, 
0.02  % was applied for 20 to 40 seconds in all 
cases. The duration of MMC application was 
selected based on the range of myopia. 
Routine follow-up examinations were 
scheduled at days 1, 3, 7 and 9, and then 
every month for 3 months. Patients had 
free access to their surgeon in case any 
complications developed. Since infectious 
keratitis was the first differential diagnosis, 
the patients with CTK were examined daily 
for two weeks. Complete eye examinations 
including best-corrected distance visual acuity 
(BCDVA), manifest refraction and slit lamp 
biomicroscopy were performed at all follow 
up visits. Time to clearing of the opacification 
was also recorded.
Results
The patients reported pain and decreased 
vision 3 to 9 days after surface laser refractive 
surgery. At the time of presentation, the mean 
BCDVA was 20/25 (LogMAR 0.83 ±  0.34), 
ranging from 20/320 (counting finger) to 
20/50. Manifest refraction exhibited an 
average hyperopic shift of + 4.15 ± 1.16 D 
ranging from + 2.50 D to + 6.50 D immediately 
after the development of CTK. Slit-lamp 
examination revealed central corneal opacities 
and corneal thinning. Topography showed 
corneal flattening (Figure 1). There was no 
conjunctival injection or anterior chamber 
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reaction. The patients received frequent 
topical corticosteroid, tapered off over 2 
months. Mean follow-up period was 14 ± 2 
months (range12 to 16 months). 
Table 1 presents the patients’ data. As shown, 
the opacification persisted for a minimum of 
two months to a maximum of 6 months before 
complete clearing (average 4 months). The 
mean final BCDVA was 20/20 (LogMAR 
0.0 ± 0.66). At 6 months postoperative, all eyes 
gained a BCDVA of 20/20 except two eyes 
that showed one and two lines of reduction in 
final BCDVA. Mean final spherical equivalent 
refraction and refractive astigmatism were 
+ 0.15 and - 0.67, respectively. All eyes 
developed significant hyperopia and 
astigmatism during the follow-up period, 
which resolved totally in 4 eyes at the final 
follow up. 
Discussion
CTK is described as a clinical syndrome of 
acute visual impairment after laser corneal 
refractive surgeries.  It has not been reported 
after enhancement surgeries. It is characterized 
by non-inflammatory central corneal opacity, 
stromal shrinkage, and hyperopic shift. 
The condition generally occurs after laser 
surface ablation. CTK occurs 3 to 9 days 
postoperatively and some eyes show visible 
corneal thinning. There is a hyperopic shift 
that may be related to corneal thinning and 
flattening.
The etiology of this entity is unclear. Several 
hypotheses have been made 1, 2, 3. Sonmez 
et al.,  3 suggested that CTK is not solely 
an intrinsic patient response and some 
external inciting factors are necessary for its 
development. The fact that CTK always occurs 
in the area of laser ablation suggests that the 
ultraviolet laser energy plays some role. The 
condition may be related to substances that are 
photo activated by laser treatments 3,4. 
These proposed substances include povidone-
iodine solutions, meibomian gland secretions, 
hemoglobin, microkeratome oil, marking-
pen materials, carboxymethylcellulose drops, 
and bacterial endotoxins 5-8. The presence 
of unknown materials on bandage contact 
lenses, used after surgery, is also proposed as 
a possible etiology. Neira et al., 9 suggested 
that carefully rinsing the contact lens before 
fitting may decrease the incidence of CTK. 
In addition, epithelial defects occurring at 
the time of surgery can be a trigger 5-8. The 
presence of CTK in eyes after PRK suggests 
it is unrelated to the flap or the microkeratome 
itself.  
There is no consensus on the pathogenesis 
of CTK. Fraenkel et al., 2 and Parolini et 
al., 4 proposed that CTK is an inflammatory 
response and considered it as a form of 
DLK grade IV. Reporting a larger series 
of patients who developed CTK, however, 
Sonmez and Maloney 3 suggested that CTK 
Figure 1: Corneal flattening in topography 
in a patient with CTK
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is not an inflammatory reaction and can be 
differentiated from diffuse lamellar keratitis 
(DLK) clinically. The mechanism of corneal 
thinning and flattening is believed to be 
due to keratocyte apoptosis or enzymatic 
degradation. Keratocyte apoptosis can 
be triggered by abnormal hypersensitive 
response to substances such as mediators in 
the tear film.  Mud crack appearance striae 
might appear as some clear refractile lines 
in the opacified background. Presence of 
striae suggests the stromal collapse in CTK 3. 
Keratocyte apoptosis has also been suggested 
by confocal scan studies. Scott et al., 10 
reported in vivo confocal microscopy in a post 
LASIK, CTK patient. They observed large 
areas of hyper reflectivity in the sub-epithelial 
and bowman layers without any keratocytes or 
inflammatory cells 10. Based on these findings 
they agreed with the hypothesis of keratocytes 
apoptosis in the acute phase of CTK 10. 
Several anterior OCT analyses in patients 
with CTK have revealed flattening of anterior 
corneal curvature and thinning of anterior 
stromal bed, that might induce the hyperopic 
shift seen in CTK 11. Serial confocal microscopy 
has indicated reappearance and regeneration 
of keratocytes without the aggregation of 
inflammatory cells, which explains the lack of 
response to topical steroids 12.
Differential diagnosis of CTK include: diffuse 
lamellar keratitis (DLK), sub epithelial 
haziness after PRK and acute infectious 
keratitis (Table 2). CTK is most often confused 
with corneal ulcer. Corneal ulcer, however, 
can be readily differentiated from CTK via 
recognition of clinical features as well as 
through careful observation and attention to 
Table1: Demographic and clinical data of patients entering the present study who developed central toxic keratopathy after photorefractive keratectomy (PRK), or laser-assisted subepithelial keratectomy (LASEK) 
Patient
Number




















1 22y Male OD - 5.50 20/20 PRK 9 + 3.0 6 Plano - 2.0 × 10 Plano-1.5 × 10 20/15 20/25 NIDEK
OS - 4.5 - 1.0 × 170 20/20 PRK 9 + 4.0 6 Plano Plano 20/20 20/20 NIDEK
2 25y Female OD – 4.5 – 0.75 × 5 20/20 LASEK 3 + 2.50 6 Plano Plano 20/20 20/20 Allegretto
OS – 4.5 - 1.25 × 
125
20/20 LASEK 3 + 3.25 6 + 1.0 - 0.75 × 15 + 0.75 - 0.75 × 
20
20/20 20/25 Allegretto
3 24y Female OD – 7.0 – 1.0 × 180 20/20 LASEK 3 + 4.0 5 Plano - 3.5 × 
180
Plano - 2.25 × 
180
20/25 20/25 Unknown
OS – 7.0 – 1.0 × 170 20/20 LASEK 3 + 3.75 5 + 2.75 - 2.0 × 
165
+ 2.00 - 1.75 × 
170
20/25 20/32 Unknown
4 56y Female OD + 2.5 - 1.0 × 90 20/20 LASEK 4 + 4.50 4 Plano Plano 20/20 20/20 Allegretto
OS + 2.5 - 0.75 × 
112
20/20 LASEK 4 + 5.0 4 Plano Plano 20/20 20/20 Allegretto
5 24y Female OD - 4.50 D 20/20 LASEK 3 + 6.50 6 + 1.5 - 1.0 × 180 + 1.25 - 0.50 × 
180
20/20 20/25 Allegretto
OS - 6.0 - 1.25 × 
180
20/20 LASEK 3 + 5.0 6 + 1.25 + 1.0 20/15 20/20 Allegretto
Table1: Demographic and clinical data of patients entering the present study who 
developed central toxic keratopathy after photorefractive keratectomy (PRK), or 
laser-assisted subepithelial keratectomy (LASEK) 
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Figure 3: Central toxic keratopathy 
opacification
Figure 2: Typical subepithelial haze after 
PRK
onset of clinical findings. Another differential 
diagnosis is haze formation after PRK. The 
typical haze after PRK is sub-epithelial 
and occurs three months postoperatively 
(Figure 2), whereas in CTK, the opacification 
lies in the anterior and mid stroma and occurs 
during the first postoperative week 3,11,13,14 
(Figure 3). Also, it is important to distinguish 
CTK from the sub-epithelial infiltrates 
syndrome occurring after PRK. Teal et al., 15 
first described this syndrome, as sub-epithelial 
inflammations after PRK in patients using 
topical non-steroidal anti-inflammatory drugs 
(NSAID) postoperatively. The opacities 
are multiple and more peripheral than CTK 
opacity. None of our patients received topical 
NSAIDS postoperatively.
CTK is self limited and many authors have 
described its resolution without any treatment. 
In the majority of our cases, the opacification 
resolved over a period of 2 to 6 months and 
most patients obtained BCDVA of 20/20. 
Our findings show that corneal curvature and 
thickness are restored after healing, resulting 
in the resolution of induced hyperopia. None 
of our patients required further surgery. The 
Tabel 2: Differential diagnosis of central toxic keratopathy
Finding CTK DLK Post PRK haziness Acute infectious keratitis
Time of onset 3 to 9 First day After one month Within 3 days of surgery
Inflammation Noninflammatory Mild to severe Noninflammatory Inflammation + AC 
reaction







Hyperopic shift Yes No No No
Procedure LASIK, PRK LASIK PRK LASIK, PRK
Time to resolution 2 to 18 months One week Months to years Weeks
CTK: Central toxic keratopathy; DLK: Diffuse lamellar keratitis; LASIK: Laser-assisted in situ keratomileusis; 
AC: Anterior chamber 
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use of steroids in these patients might not 
improve the clinical outcome 16,17. However; 
it can aggravate corneal thinning caused by 
CTK. 
This study had some limitations. We could not 
report the confocal scan or OCT findings as 
we had no access to these imaging techniques 
at the time of the study. In addition, alterations 
in corneal curvature over time could not be 
assessed in this study due to lack of access to 
corneal tomographies including Orbscan and 
Pentacam. 
Conclusion
Central toxic keratopathy is a 
non-inflammatory central corneal opacification 
which is associated with significant hyperopic 
shift and stromal tissue loss. Visual 
prognosis is usually good, but a decrease in 
best-corrected distance visual acuity may 
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